Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $141.9900 (2.65%) ($137.7580 - $142.7200) on Tue. Oct. 4, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.53% (three month average) | RSI | 55 | Latest Price | $141.9900(2.65%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV declines -0.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(27%) DIA(24%) SPLV(22%) XLP(21%) VYM(20%) | Factors Impacting ABBV price | ABBV will decline at least -0.765% in a week (0% probabilities). VIXM(-14%) UUP(-14%) TBT(-6%) UNG(0%) VXX(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.765% (StdDev 1.53%) | Hourly BBV | 1.3 () | Intraday Trend | 2% | | | |
|
5 Day Moving Average | $140.37(1.15%) | 10 Day Moving Average | $141.06(0.66%) | 20 Day Moving Average | $141.15(0.6%) | To recent high | -7.8% | To recent low | 5.8% | Market Cap | $250.511b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |